L-Arginine Treatment for Severe Vascular Fetal Intrauterine Growth Restriction: a Randomized Double Bind Controlled Trial (L Arginine in IUGR)

NCT00549575 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

44

Enrollment

OTHER

Sponsor class

Stopped terminated

Conditions

Intra Uterine Growth Retardation

Interventions

DRUG: L ARG
DRUG: Placebo

Sponsor

Nantes University Hospital